Does the addition of standard systematic biopsies to targeted prostate biopsies influence treatment choices for patients and clinicians?

Authors

William Behl, Virginia Commonwealth UniversityFollow
Jinxing Yu MD, Virginia Commonwealth UniversityFollow

Document Type

Poster

Original Publication Date

2016

Date of Submission

August 2016

Abstract

Addition of standard systematic prostate biopsy to targeted biopsy in patients with elevated PSA and no prior systematic prostate biopsy within the preceding 3 years detected PCa GS ≥ 7 on the opposite side of the prostate from the target lesions (with no significant abnormalities on mp-MRI) in 13% of patients. This result may influence treatment choices, particularly for those patients considering focal therapy for PCa.

Is Part Of

VCU School of Medicine MD Student Summer Research Fellowship Program Posters